Literature DB >> 18541822

Characteristics and outcomes in African American patients with decompensated heart failure.

Sandeep A Kamath1, Mark H Drazner, Janet Wynne, Gregg C Fonarow, Clyde W Yancy.   

Abstract

BACKGROUND: Outcomes in patients with chronic heart failure vary by race. Racial differences in the characteristics and outcomes of patients with acute decompensated heart failure (ADHF) have not been well characterized. Therefore, we assessed race-related differences in presentation, treatment, in-patient experiences, and short-term mortality due to ADHF before and after accounting for known covariates.
METHODS: The Acute Decompensated Heart Failure National Registry database was analyzed to evaluate demographic and mortality differences in African American and white patients with ADHF entered into the database from its initiation in September 2001 to December 31, 2004. Stratified analyses by cause, age, left ventricular function, and history of heart failure subgroups were also conducted.
RESULTS: A total of 105,872 episodes of ADHF occurred in white patients and 29,862 occurred in African American patients. African American patients with ADHF were younger than white patients (mean [SD] age, 63.5 [15.4] vs 72.5 [12.5] years) and had lower mean left ventricular ejection fractions. The prevalence of hypertension, diabetes mellitus, and obesity was higher in African American patients. African American race was associated with lower in-hospital mortality after adjustment for known predictors (2.1% vs 4.5%; adjusted odds ratio [OR], 0.79; 95% confidence interval [CI], 0.72-0.87; P < .001). This association persisted for all age cohorts, was independent of the use of intravenous vasoactive drugs, and was especially present in African American patients in the nonischemic subgroup (adjusted OR, 0.74; 95% CI, 0.57-0.96) but not the ischemic subgroup (adjusted OR, 0.91; 95% CI, 0.76-1.09).
CONCLUSION: In ADHF, African American race is associated with lower in-hospital mortality compared with white race, despite certain indicators of increased disease severity.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18541822     DOI: 10.1001/archinte.168.11.1152

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


  19 in total

1.  Isosorbide dinitrate and hydralazine as therapy for African Americans with heart failure; a failed paradigm?

Authors:  Clyde W Yancy; Arthur Feldman
Journal:  Clin Transl Sci       Date:  2009-08       Impact factor: 4.689

2.  Racial and Ethnic Differences in Heart Failure Readmissions and Mortality in a Large Municipal Healthcare System.

Authors:  Matthew S Durstenfeld; Olugbenga Ogedegbe; Stuart D Katz; Hannah Park; Saul Blecker
Journal:  JACC Heart Fail       Date:  2016-07-06       Impact factor: 12.035

Review 3.  Global perspectives in hospitalized heart failure: regional and ethnic variation in patient characteristics, management, and outcomes.

Authors:  Andrew P Ambrosy; Mihai Gheorghiade; Ovidiu Chioncel; Robert J Mentz; Javed Butler
Journal:  Curr Heart Fail Rep       Date:  2014-12

4.  Race, exercise training, and outcomes in chronic heart failure: findings from Heart Failure - a Controlled Trial Investigating Outcomes in Exercise TraiNing (HF-ACTION).

Authors:  Robert J Mentz; Vera Bittner; Phillip J Schulte; Jerome L Fleg; Ileana L Piña; Steven J Keteyian; Gordon Moe; Anil Nigam; Ann M Swank; Anekwe E Onwuanyi; Meredith Fitz-Gerald; Andrew Kao; Stephen J Ellis; William E Kraus; David J Whellan; Christopher M O'Connor
Journal:  Am Heart J       Date:  2013-07-12       Impact factor: 4.749

5.  Communication Strategies Must Be Tailored to a Medication's Targeted Population: Lessons from the Case of BiDil.

Authors:  Chamika Hawkins-Taylor; Angeline M Carlson
Journal:  Am Health Drug Benefits       Date:  2013-09

6.  Capsule commentary on Zhang et al., Race/ethnicity, disability, and medication adherence among medicare beneficiaries with heart failure.

Authors:  Paul A Heidenreich
Journal:  J Gen Intern Med       Date:  2014-04       Impact factor: 5.128

Review 7.  Transthyretin Cardiac Amyloidosis in Black Americans.

Authors:  Keyur B Shah; Anit K Mankad; Adam Castano; Olakunle O Akinboboye; Phillip B Duncan; Icilma V Fergus; Mathew S Maurer
Journal:  Circ Heart Fail       Date:  2016-06       Impact factor: 8.790

8.  Racial Differences in Diuretic Efficiency, Plasma Renin, and Rehospitalization in Subjects With Acute Heart Failure.

Authors:  Alanna A Morris; Aditi Nayak; Yi-An Ko; Melroy D'Souza; G Michael Felker; Margaret M Redfield; W H Wilson Tang; Jeffrey M Testani; Javed Butler
Journal:  Circ Heart Fail       Date:  2020-07-08       Impact factor: 8.790

9.  The complex relationship of race to outcomes in heart failure with preserved ejection fraction.

Authors:  Jerry H Gurwitz; David J Magid; David H Smith; Grace Hsu; Sue Hee Sung; Larry A Allen; David D McManus; Robert J Goldberg; Alan S Go
Journal:  Am J Med       Date:  2014-12-30       Impact factor: 4.965

10.  Heart failure with preserved ejection fraction in African Americans: The ARIC (Atherosclerosis Risk In Communities) study.

Authors:  Deepak K Gupta; Amil M Shah; Davide Castagno; Madoka Takeuchi; Laura R Loehr; Ervin R Fox; Kenneth R Butler; Thomas H Mosley; Dalane W Kitzman; Scott D Solomon
Journal:  JACC Heart Fail       Date:  2013-04       Impact factor: 12.035

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.